what are cdk 4/6 inhibitors for breast cancer?
Published 1 year ago • 6.5K plays • Length 7:59Download video MP4
Download video MP3
Similar videos
-
21:11
current clinical data for cdk 4/6 inhibitors in breast cancer
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
8:28
cdk4/6 inhibition in breast cancer
-
20:19
expert discussion on cdk 4/6 inhibition in breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
4:52
future directions: cdk4/6 inhibitors in breast cancer
-
3:50
cdk4/6 inhibitors in metastatic breast cancer
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
9:42
expert perspectives: rationale for cdk 4/6 inhibition in breast cancer
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
5:34
considerations for treating patients with cdk4/6 inhibitors
-
5:07
what is the role of cdk4/6 inhibitors in early breast cancer?
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer